Advances in interdisciplinary medical and engineering research of intraocular lens surface modifications to prevent posterior capsule opacification.
人工晶状体表面处理预防后发性白内障的医工交叉研究进展.
cataract
intraocular lens surface modification
posterior capsule opacification
Journal
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
ISSN: 1672-7347
Titre abrégé: Zhong Nan Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101230586
Informations de publication
Date de publication:
28 Dec 2022
28 Dec 2022
Historique:
entrez:
7
2
2023
pubmed:
8
2
2023
medline:
9
2
2023
Statut:
ppublish
Résumé
Posterior capsule opacification (PCO), a common complication after cataract surgery, impacts a patient's long-term visual quality to various degrees. Although a neodymium:yttrium aluminum garnet (Nd:YAG) laser posterior capsulotomy is a very effective treatment, it may lead to a serial of complications. Accordingly, the search for simple, safe, and effective methods to prevent PCO has received widespread attention. Various researchers are committed to the interdisciplinary collaboration between medicine and engineering fields, such as functionalizing the surface of the intraocular lens (IOL) via supercritical fluid impregnation, coating the surface of the IOL, high-concentration drug immersion, and application of a drug delivery system, to effectively reduce the incidence and severity of PCO. 后发性白内障(posterior capsule opacification，PCO)是白内障术后最常见的并发症之一，不同程度地影响了白内障术后患者的远期视觉质量。虽然掺钕钇铝石榴石(neodymium:yttrium aluminum garnet，Nd:YAG)激光后囊膜切开对于治疗PCO非常有效，但其可能会带来一系列并发症。因此，寻找简单、安全、有效防治PCO的方法受到了广泛的关注。目前，众多研究者致力于医工交叉领域，从人工晶状体(intraocular lens，IOL)表面入手，通过使用超临界流体浸渍、IOL表面涂层、高浓度药物浸泡、药物递送系统(drug delivery system，DDS)等方法，使IOL功能化，有效降低了PCO的发生率及其严重程度。.
Autres résumés
Type: Publisher
(chi)
后发性白内障(posterior capsule opacification，PCO)是白内障术后最常见的并发症之一，不同程度地影响了白内障术后患者的远期视觉质量。虽然掺钕钇铝石榴石(neodymium:yttrium aluminum garnet，Nd:YAG)激光后囊膜切开对于治疗PCO非常有效，但其可能会带来一系列并发症。因此，寻找简单、安全、有效防治PCO的方法受到了广泛的关注。目前，众多研究者致力于医工交叉领域，从人工晶状体(intraocular lens，IOL)表面入手，通过使用超临界流体浸渍、IOL表面涂层、高浓度药物浸泡、药物递送系统(drug delivery system，DDS)等方法，使IOL功能化，有效降低了PCO的发生率及其严重程度。.
Identifiants
pubmed: 36748388
pii: 1672-7347(2022)12-1754-09
doi: 10.11817/j.issn.1672-7347.2022.220277
pii:
doi:
Types de publication
Journal Article
Langues
eng
chi
Sous-ensembles de citation
IM
Pagination
1754-1762Subventions
Organisme : the National Natural Science Foundation
ID : 81974130
Organisme : the Natural Science Foundation of Hunan Province
ID : 2020JJ4882
Références
J Mater Chem B. 2015 May 14;3(18):3695-3703
pubmed: 32262844
Int J Biol Macromol. 2021 Jan 1;166:144-154
pubmed: 33190824
J Cataract Refract Surg. 2020 Aug;46(8):1092-1101
pubmed: 32352250
J Cataract Refract Surg. 2020 Jan;46(1):102-107
pubmed: 32050239
J Control Release. 2020 Oct 10;326:245-255
pubmed: 32682901
Acta Ophthalmol. 2020 May;98(3):e328-e332
pubmed: 31559703
J Cataract Refract Surg. 2019 Oct;45(10):1380-1385
pubmed: 31564312
J Control Release. 2021 Nov 10;339:391-402
pubmed: 34563593
Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1529-40
pubmed: 23329402
Adv Healthc Mater. 2020 Sep;9(18):e2000447
pubmed: 32743966
Eur J Pharm Biopharm. 2012 Oct;82(2):383-91
pubmed: 22846620
Eur J Ophthalmol. 2021 Mar;31(2):436-444
pubmed: 31789061
J Mater Chem B. 2021 Feb 14;9(6):1546-1556
pubmed: 33527973
Chin Med J (Engl). 2016 Jan 20;129(2):206-14
pubmed: 26830993
PLoS One. 2016 Oct 14;11(10):e0163857
pubmed: 27741256
Int J Pharm. 2016 Mar 16;500(1-2):85-99
pubmed: 26780123
Ophthalmology. 2020 Apr;127(4S):S27-S28
pubmed: 32200822
Int J Pharm. 2021 Jun 1;602:120613
pubmed: 33865952
J Ocul Pharmacol Ther. 2021 Apr;37(3):172-180
pubmed: 33497580
RSC Adv. 2022 Mar 7;12(12):7403-7404
pubmed: 35427043
Curr Med Res Opin. 2019 Nov;35(11):1971-1981
pubmed: 31328581
Colloids Surf B Biointerfaces. 2017 Mar 1;151:271-279
pubmed: 28027493
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283655
Colloids Surf B Biointerfaces. 2013 Nov 1;111:15-23
pubmed: 23787277
Mol Med Rep. 2020 Jul;22(1):551-558
pubmed: 32377724
Int J Nanomedicine. 2019 Nov 19;14:9047-9061
pubmed: 31819418
Adv Mater. 2017 Mar;29(11):
pubmed: 28032923
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):409-17
pubmed: 25471020
Eur J Pharm Biopharm. 2020 Apr;149:248-256
pubmed: 32112896
Klin Monbl Augenheilkd. 2016 Feb;233(2):172-8
pubmed: 26878733
J Cataract Refract Surg. 2017 Oct;43(10):1343-1349
pubmed: 29120719
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4986-4997
pubmed: 30326070
Acta Ophthalmol. 2018 Nov;96(7):e874-e882
pubmed: 29855160
Rom J Ophthalmol. 2018 Jul-Sep;62(3):188-193
pubmed: 30505987
Prog Retin Eye Res. 2021 May;82:100905
pubmed: 32977000
Int J Mol Sci. 2019 Apr 27;20(9):
pubmed: 31035577
Biomacromolecules. 2021 Aug 9;22(8):3510-3521
pubmed: 34288655
Am J Ther. 2016 Jan-Feb;23(1):e98-117
pubmed: 21048433
Lancet Oncol. 2018 Dec;19(12):1630-1640
pubmed: 30413379
Exp Eye Res. 2021 Jan;202:108282
pubmed: 33049272
J Cataract Refract Surg. 2015 Aug;41(8):1738-44
pubmed: 26432133
Exp Eye Res. 2022 Aug;221:109135
pubmed: 35662618
Biomacromolecules. 2007 Aug;8(8):2379-87
pubmed: 17608449
Biomaterials. 2010 Mar;31(8):2399-407
pubmed: 20022368
Lancet. 2017 Aug 5;390(10094):600-612
pubmed: 28242111
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5785-5794
pubmed: 30521667
J Biomater Sci Polym Ed. 2021 Apr;32(6):735-748
pubmed: 33332253
Int J Pharm. 2020 May 15;581:119247
pubmed: 32209368
J Cataract Refract Surg. 2015 Jul;41(7):1484-9
pubmed: 26210048
J Cataract Refract Surg. 2015 Jul;41(7):1478-83
pubmed: 26210051
Acta Biomater. 2022 Jan 15;138:327-341
pubmed: 34800717
Eur J Pharm Biopharm. 2018 Dec;133:63-69
pubmed: 30292794
Pharmaceutics. 2021 Jun 10;13(6):
pubmed: 34200928
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110418
pubmed: 31924030
J Biomater Appl. 2016 Jul;31(1):68-76
pubmed: 26980548
J Biomed Mater Res A. 2019 Sep;107(9):1909-1916
pubmed: 30950154
Pharmaceutics. 2019 Nov 25;11(12):
pubmed: 31775292
J Cataract Refract Surg. 1999 Nov;25(11):1486-91
pubmed: 10569163
Bioact Mater. 2021 Jul 23;9:343-357
pubmed: 34820575
J Mater Chem B. 2021 Jan 28;9(3):793-800
pubmed: 33336672
J Cataract Refract Surg. 2019 Dec;45(12):1732-1737
pubmed: 31856983
Turk J Ophthalmol. 2017 Aug;47(4):221-225
pubmed: 28845327
ACS Appl Mater Interfaces. 2015 Jun 17;7(23):12882-93
pubmed: 25992843
J Colloid Interface Sci. 2013 Aug 15;404:207-14
pubmed: 23711662